-
-
This paper reviews the recent data on the effectiveness of cardiac resynchronization therapy (CRT) in patients with milder forms of heart failure (NYHA classes 1 and 2) and revises the Heart Failure Society of America's (HFSA) 2010 Guidelines.
-
This report from a consortium of Canadian implantable cardioverter-defibrillator (ICD) implantation centers analyzed predictors of failure of the Medtronic Sprint Fidelis lead.
-
For those who perform percutaneous coronary intervention (PCI), the newer generation stents have obvious benefits during the procedure.
-
Statins and diabetes risk; new treatment guideline for diabetes; new pertussis vaccine recommendation; antibiotics and rhinosinusitis; fluoroquinolones and cystitis; and FDA actions.
-
The value of high sensitivity C-reactive protein (CRP) measurements in the management of patients at risk for cardiovascular (CV) events is controversial.
-
Although a routine part of a complete medical history, the value of systematically collecting family history has not been shown in controlled trials.
-
Timely recognition and treatment of myocardial infarction (MI) are crucial if we are to achieve optimal outcomes for our patients.
-
In patients with severe coronary artery disease (CAD) and depressed left ventricular (LV) function, coronary artery bypass graft (CABG) surgery remains the recommended treatment.
-
Beta-blockers have long been a cornerstone of therapy for patients who have suffered myocardial infarction (MI). However, most studies of beta blockade following MI were performed before the current era of reperfusion therapy, statins, and antiplatelet agents.
